DK3274710T3 - Forbedrede assays til måling af styrken af humane retinale pigmentepitel (rpe)-celler og fotoreceptorprogenitorer - Google Patents

Forbedrede assays til måling af styrken af humane retinale pigmentepitel (rpe)-celler og fotoreceptorprogenitorer Download PDF

Info

Publication number
DK3274710T3
DK3274710T3 DK16716342.7T DK16716342T DK3274710T3 DK 3274710 T3 DK3274710 T3 DK 3274710T3 DK 16716342 T DK16716342 T DK 16716342T DK 3274710 T3 DK3274710 T3 DK 3274710T3
Authority
DK
Denmark
Prior art keywords
pitles
photor
rpe
progenitors
receptor
Prior art date
Application number
DK16716342.7T
Other languages
English (en)
Inventor
Irina V Klimanskaya
Yordanka Gikova Ivanova
Julie Kathryn Carson
Roger Gay
Original Assignee
Astellas Inst For Regenerative Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Inst For Regenerative Medicine filed Critical Astellas Inst For Regenerative Medicine
Application granted granted Critical
Publication of DK3274710T3 publication Critical patent/DK3274710T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Electro-optical investigation, e.g. flow cytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6486Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/16Ophthalmology
    • G01N2800/164Retinal disorders, e.g. retinopathy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK16716342.7T 2015-03-23 2016-03-23 Forbedrede assays til måling af styrken af humane retinale pigmentepitel (rpe)-celler og fotoreceptorprogenitorer DK3274710T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562136660P 2015-03-23 2015-03-23
PCT/US2016/023839 WO2016154357A1 (en) 2015-03-23 2016-03-23 Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors

Publications (1)

Publication Number Publication Date
DK3274710T3 true DK3274710T3 (da) 2021-09-06

Family

ID=55752717

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16716342.7T DK3274710T3 (da) 2015-03-23 2016-03-23 Forbedrede assays til måling af styrken af humane retinale pigmentepitel (rpe)-celler og fotoreceptorprogenitorer

Country Status (16)

Country Link
US (3) US11422125B2 (da)
EP (3) EP4343331A2 (da)
JP (3) JP6902474B2 (da)
KR (2) KR20230132893A (da)
CN (2) CN107889507B (da)
AU (2) AU2016235176B2 (da)
CA (2) CA2980580C (da)
DK (1) DK3274710T3 (da)
ES (1) ES2877400T3 (da)
HU (1) HUE054946T2 (da)
IL (3) IL293110B2 (da)
MX (2) MX2017012259A (da)
PL (1) PL3274710T3 (da)
PT (1) PT3274710T (da)
SG (3) SG11201707775TA (da)
WO (1) WO2016154357A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012012803A2 (en) 2010-07-23 2012-01-26 Advanced Cell Technology, Inc. Methods for detection of rare subpopulations of cells and highly purified compositions of cells
PT3274710T (pt) 2015-03-23 2021-07-06 Astellas Inst For Regenerative Medicine Ensaios melhorados para potência de células de epitélio pigmentar da retina (rpe) humana e de progenitoras de fotorrecetores
SG10201913250SA (en) 2015-08-18 2020-03-30 Astellas Inst For Regenerative Medicine Clinical formulations
IL292610A (en) 2019-10-30 2022-07-01 Astellas Inst For Regenerative Medicine Methods for the production of retinal pigment epithelial cells
DE102022103893A1 (de) * 2022-02-18 2023-08-24 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Membranvesikel, die einen spektroskopisch nachweisbaren Indikator beinhalten, und deren Verwendung in einem Verfahren zum Nachweis der Phagozytose-Funktion bei biologischen Zellen

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432711B1 (en) 1993-11-03 2002-08-13 Diacrin, Inc. Embryonic stem cells capable of differentiating into desired cell lines
US20110171185A1 (en) 1999-06-30 2011-07-14 Klimanskaya Irina V Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof
US20040199935A1 (en) 1999-06-30 2004-10-07 Chapman Karen B. Cytoplasmic transfer to de-differentiate recipient cells
MXPA01013450A (es) 1999-06-30 2003-09-04 Advanced Cell Tech Inc Transferencia citoplasmica para celulas receptoras de-diferenciacion.
US20040180430A1 (en) 1999-09-07 2004-09-16 West Michael D. Methods of restoring telomere length and extending cell lifespan using nuclear transfer
WO2001018236A1 (en) 1999-09-07 2001-03-15 Advanced Cell Technology, Inc. Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells
US20050255596A1 (en) 1999-09-07 2005-11-17 West Michael D Methods of repairing tandemly repeated DNA sequences and extending cell life-span nuclear transfer
JP2003512848A (ja) 1999-11-02 2003-04-08 ユニバーシティ オブ マサチューセッツ、アズ リプリゼンティッド バイ イッツ アマースト キャンパス 遺伝的診断、修飾および増殖のための一倍体ゲノムの使用
EP1241936A4 (en) 1999-12-20 2006-04-05 Anthony C F Perry PROCESS FOR PRODUCING EMBRYOS AND CLONED ADULTS FROM CULTIVATED CELLS
CA2394614A1 (en) 1999-12-20 2001-06-28 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Embryonic or stem-like cells produced by cross species nuclear transplantation
US20020132346A1 (en) 2001-03-08 2002-09-19 Jose Cibelli Use of RNA interference for the creation of lineage specific ES and other undifferentiated cells and production of differentiated cells in vitro by co-culture
WO2002073188A1 (en) 2001-03-13 2002-09-19 Advanced Cell Technology, Inc. Method for generating replacement cells and/or tissues
CA2458575C (en) 2001-08-24 2014-07-08 Advanced Cell Technology, Inc. Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
WO2004060056A2 (en) 2002-12-27 2004-07-22 Advanced Cell Technology, Inc. Sperm-induced cellular activation
CA2552288C (en) 2004-01-02 2015-02-24 Advanced Cell Technology, Inc. Novel culture systems for ex vivo development
US20190282622A1 (en) 2004-01-23 2019-09-19 Astellas Institute For Regenerative Medicine Modalities for the treatment of degenerative diseases of the retina
US7794704B2 (en) 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
EP4248752A3 (en) 2004-01-23 2024-01-03 President And Fellows Of Harvard College Improved modalities for the treatment of degenerative diseases of the retina
GB0407836D0 (en) 2004-04-06 2004-05-12 Univ Cambridge Tech Fluorescent dyes and complexes
AU2005304978A1 (en) 2004-11-04 2006-05-18 Advanced Cell Technology, Inc. Derivation of embryonic stem cells
US7893315B2 (en) 2004-11-04 2011-02-22 Advanced Cell Technology, Inc. Derivation of embryonic stem cells and embryo-derived cells
US20060263338A1 (en) 2005-03-04 2006-11-23 Jacoby Douglas B Catheter-based delivery of Skeletal Myoblasts to the Myocardium of Damaged Hearts
US8889122B2 (en) 2005-05-09 2014-11-18 Mytogen, Inc. Cellular cardiomyoplasty as supportive therapy in patients with heart disease
ES2933478T3 (es) 2005-08-03 2023-02-09 Astellas Inst For Regenerative Medicine Métodos mejorados de reprogramación de células somáticas animales
US20090271335A1 (en) 2005-10-20 2009-10-29 Advanced Cell Technology, Inc. Totipotent, Nearly Totipotent or Pluripotent Mammalian Cells Homozygous or Hemizygous for One or More Histocompatibility Antigent Genes
EP2612906A3 (en) 2006-05-03 2013-12-11 Advanced Cell Technology, Inc. Derivation of embryonic stem cells and embryo-derived cells
EP3190178A1 (en) 2007-02-23 2017-07-12 Astellas Institute for Regenerative Medicine Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells
PL2209888T3 (pl) 2007-10-12 2020-05-18 Astellas Institute For Regenerative Medicine Ulepszony sposób wytwarzania komórek rpe i kompozycji komórek rpe
US20110028780A1 (en) 2007-12-19 2011-02-03 Robert Lanza Methods Of Producing Pluripotent Stem Cell-Generated Embryos, And Animals Derived Therefrom
KR20120102709A (ko) 2009-11-17 2012-09-18 어드밴스드 셀 테크놀로지, 인코포레이티드 인간 rpe 세포의 생산 방법 및 인간 rpe 세포의 제약 제제
WO2012012803A2 (en) 2010-07-23 2012-01-26 Advanced Cell Technology, Inc. Methods for detection of rare subpopulations of cells and highly purified compositions of cells
US20120184035A1 (en) 2011-01-13 2012-07-19 Sadhana Agarwal Methods and Compositions For Reprogramming Cells
IL308205A (en) 2011-11-14 2024-01-01 Astellas Inst For Regenerative Medicine Pharmaceutical preparations of human RPE cells and their use
US8961956B2 (en) 2011-11-30 2015-02-24 Ocata Therapeutics, Inc. Mesenchymal stromal cells and uses related thereto
LT2785359T (lt) 2011-11-30 2018-11-12 Astellas Institute For Regenerative Medicine Mezenchiminės stromos ląstelės ir su jomis susiję naudojimo būdai
CA3178138A1 (en) 2011-12-06 2013-06-13 Astellas Institute For Regenerative Medicine Method of directed differentiation producing corneal endothelial cells, compositions thereof, and uses thereof
US9511152B2 (en) 2012-04-05 2016-12-06 The Board Of Regents Of The University Of Texas System Multicolored pH-activatable fluorescence nanoplatform
US9763984B2 (en) 2012-12-21 2017-09-19 Astellas Institute For Regenerative Medicine Methods for production of platelets from pluripotent stem cells and compositions thereof
US20160175362A1 (en) 2014-03-14 2016-06-23 Ocata Therapeutics, Inc. Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
US20160175361A1 (en) 2014-03-14 2016-06-23 Advanced Cell Technology, Inc. Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
US11241460B2 (en) 2013-03-15 2022-02-08 Astellas Institute For Regenerative Medicine Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
PT2970903T (pt) 2013-03-15 2024-02-26 Astellas Inst For Regenerative Medicine Fotorrecetores e progenitores de fotorrecetores produzidos a partir de células estaminais pluripotentes
PT3189135T (pt) 2014-09-05 2021-08-19 Astellas Inst For Regenerative Medicine Células ganclionares retinianas e seus progenitores
PT3274710T (pt) 2015-03-23 2021-07-06 Astellas Inst For Regenerative Medicine Ensaios melhorados para potência de células de epitélio pigmentar da retina (rpe) humana e de progenitoras de fotorrecetores
SG10201913250SA (en) 2015-08-18 2020-03-30 Astellas Inst For Regenerative Medicine Clinical formulations

Also Published As

Publication number Publication date
CA2980580A1 (en) 2016-09-29
SG10201907918VA (en) 2019-10-30
EP3274710A1 (en) 2018-01-31
IL254617B (en) 2022-06-01
MX2017012259A (es) 2018-05-17
AU2022218516A1 (en) 2022-09-08
IL303401A (en) 2023-08-01
US11680941B2 (en) 2023-06-20
JP7386206B2 (ja) 2023-11-24
JP6902474B2 (ja) 2021-07-14
PT3274710T (pt) 2021-07-06
EP3274710B1 (en) 2021-06-09
EP3869195B1 (en) 2024-03-20
US20230408489A1 (en) 2023-12-21
KR20230132893A (ko) 2023-09-18
IL254617A0 (en) 2017-11-30
CN107889507A (zh) 2018-04-06
JP2018516535A (ja) 2018-06-28
KR20180011761A (ko) 2018-02-02
PL3274710T3 (pl) 2021-12-27
US11422125B2 (en) 2022-08-23
ES2877400T3 (es) 2021-11-16
KR102577776B1 (ko) 2023-09-11
CN107889507B (zh) 2021-11-26
AU2016235176A1 (en) 2017-10-26
US20230051804A1 (en) 2023-02-16
JP2021168655A (ja) 2021-10-28
IL293110A (en) 2022-07-01
CA2980580C (en) 2024-01-23
US20180052150A1 (en) 2018-02-22
WO2016154357A1 (en) 2016-09-29
AU2016235176B2 (en) 2022-05-19
CA3188112A1 (en) 2016-09-29
SG11201707775TA (en) 2017-10-30
SG10201912315UA (en) 2020-02-27
CN113930476A (zh) 2022-01-14
EP4343331A2 (en) 2024-03-27
MX2022010736A (es) 2022-09-23
JP2024037720A (ja) 2024-03-19
IL293110B1 (en) 2023-07-01
IL293110B2 (en) 2023-11-01
HUE054946T2 (hu) 2021-10-28
EP3869195A1 (en) 2021-08-25

Similar Documents

Publication Publication Date Title
CL2016002364A1 (es) Indazol-3-carboxamidas 5-sustituidas y preparación y uso de las mismas
CL2016002252A1 (es) Anticuerpos anti-egfrviii y usos de los mismos
DK3207130T3 (da) Sammensætninger af Adenosin Deaminase-2 (ADA2), varianter deraf og fremgangsmåder til anvendelse af samme
KR20180084817A (ko) 항-siglec-9 항체 및 이의 이용 방법
BR112017004648A2 (pt) simuladores mir-29 e os usos deste
DK3309174T3 (da) ANTI-PD-L1-antistoffer og diagnostiske anvendelser deraf
DK3114145T3 (da) Anti human interleukin-1-receptor-assessory-protein (il1rap) antistoffer og anvendelser deraf
CL2016002569A1 (es) Anticuerpos, composiciones farmacéuticas y usos de los mismos
DK3286206T3 (da) Hidtil ukendte hybride actriib-ligand-trap-proteiner til behandling af muskelsvindsygdomme
DK3557998T3 (da) Sammensætninger, kompositioner og anvendelsesmetoder
CL2018001139A1 (es) Anticuerpos anti-htra1 y métodos de uso de los mismos.
ZA201806436B (en) Insecticidal proteins and methods for their use
DK3331879T3 (da) Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne
DK3274710T3 (da) Forbedrede assays til måling af styrken af humane retinale pigmentepitel (rpe)-celler og fotoreceptorprogenitorer
DK3137168T3 (da) Substituerede 4-phenylpiperidiner, deres fremstilling og anvendelse
CL2016001921A1 (es) Proteínas inmovilizadas y uso de las mismas
DK3506733T3 (da) Dyrknings- og prøveudtagningsfremgangsmåde
DK3113153T3 (da) Hybrid simulator og fremgangsmåde til at undervise i optik eller til at træne instilling af en optisk indretning
DK3110837T3 (da) Tatk-cdkl5-fusionsproteiner, sammensætninger, formule-ringer og anvendelse deraf
GB201609952D0 (en) Combined optical and mass spectral tissue ID probes
CL2017002226A1 (es) Etv2 y usos de los mismos
DK3442944T3 (da) Fremgangsmåde til fremstillingen af 4-aminoindanderivater og relaterede aminoindanamider
BR112017012240A2 (pt) métodos de preparação de composições contendo alcaloides e suas utilizações
BR112016021395A2 (pt) métodos de geração de uma célula pluripotente e de preparação de uma célula ou tecido ensaio, uso de uma célula pluripotente, e, composição
DK3475310T3 (da) Umættede derivater af polysaccharider, fremgangsmåder til fremstilling deraf og anvendelse deraf